FDA Approves First Test to Spot Folks at High Risk of Opioid Use Disorder

THURSDAY, Dec. 21, 2023 -- A newly approved test can determine whether a person has a genetically driven risk of becoming addicted to opioids.

The AvertD test, the first of its kind, uses a DNA sample swabbed from a patient’s cheek to...